BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Drug Development

  Mologen: Positive Subgroup Results Of The Exploratory Phase II IMPULSE Study Of Lefitolimod In Extensive-Disease Small-Cell Lung Cancer (SCLC)

  April 24, 2017

   · 

  7 min read
• Drug Development

  Achillion Announces Additional Phase II Results Including 100% SVR24 For Genotype 1 HCV After 6-Weeks Of Once Daily JNJ-4178

  April 24, 2017

   · 

  8 min read
• Drug Development

  Pfizer Receives Positive CHMP Opinion For BESPONS (Inotuzumab Ozogamicin) For The Treatment Of Relapsed Or Refractory Acute Lymphoblastic Leukemia

  April 24, 2017

   · 

  9 min read
• Business

  Aerie Announces Appointment Of Raymond S. Wysmierski As Director Of Compliance

  April 24, 2017

   · 

  4 min read
• Business

  Active Wound Management Innovations: APR Applied Pharma Research S.A. And ATG Allied Technologies Group Sign A Partnership To Distribute The Innovative Active Cleanser Nexodyn® AOS Into Germany And Turkey Markets

  April 24, 2017

   · 

  6 min read
• Drug Development

  Biogen’s SPINRAZA (Nusinersen) Receives Positive CHMP Opinion For The Treatment Of Spinal Muscular Atrophy

  April 24, 2017

   · 

  8 min read
• Biotech Bay

  Cytokinetics Added To S&P SmallCap 600

  April 24, 2017

   · 

  3 min read
• Business

  CytoSorbents Awarded $1M Phase II SBIR Contract By U.S. Department Of Defense To Advance Fungal Mycotoxin Blood Purification

  April 24, 2017

   · 

  6 min read
• Drug Development

  Gilead Announces Scientific Presentations Demonstrating Efficacy Of Harvoni (Ledipasvir/Sofosbuvir) In Special Patient Populations With HCV Infection

  April 24, 2017

   · 

  8 min read
• Drug Development

  Arbutus Biopharma Announces ARB-1467 Data Presentation At EASL

  April 24, 2017

   · 

  7 min read